Yvonne Linney - 15 Aug 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
15 Aug 2022
Net transactions value
-$64,802
Form type
4
Filing time
17 Aug 2022, 17:55:28 UTC
Previous filing
13 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Options Exercise $7,600 +20,000 $0.3800 20,000 15 Aug 2022 Direct
transaction BNGO Common Stock Sale $72,402 -20,000 -100% $3.62 0 15 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Options Exercise $0 -20,000 -25% $0.000000 60,923 15 Aug 2022 Common Stock 20,000 $0.3800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).